Open the map

LabcorpLH

Diagnostics · NYSE · USA

$314.20
Up 0.7% todayClose

Up 24.4% this year and +15.7% since June 26, ahead of the life science sector at +10.7%. Labcorp supplies 1 mapped company and buys from 4.

This year
+24.4%
1 year
+11.6%
P/E
25.4
P/S
1.8
P/B
3.0

Price vs the life science sector

since Jun 26LHLife science sector, equal weight
Labcorp (LH) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. LH: +15.7% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8LH +15.7%Sector +10.7% Labcorp (LH) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. LH: +15.7% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8LH+15.7%Sector+10.7%

Supply chain

4 suppliers · 1 customer
SUPPLIERS →→ CUSTOMERSAbbott Laboratories (ABT)ABTAbbott Laboratories−0.2%Bio-Rad Laboratories (BIO)BIOBio-Rad Laboratories−2.0%Becton Dickinson (BDX)BDXBecton Dickinson+1.4%Illumina (ILMN)ILMNIllumina−1.2%UnitedHealth (UNH)UNHUnitedHealth−1.3%LHLabcorp Open the full chain →

About Labcorp

Samples from across the US end up in Labcorp's laboratories, which handle routine clinical testing alongside genomics and specialty assays. A contract research arm works for drug developers.

Theme exposure

Clinical labsDiagnosticsGenomics

Products

  • Clinical laboratory diagnostics
  • Specialty testing & genomics
  • Laboratory services

Competitors

Risks

  • Reimbursement pressure
  • Test price declines

Same segment: Diagnostics

Tests, imaging and assays that support clinical decision-making. Segment 6 of 8 in the Medicine, pharma & life science value chain.

Compare LH

Side by side with the largest companies in the same segment.

See where Labcorp sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →